Vertex Pharmaceuticals, Inc. (VRTX)
523.93
-11.24
(-2.10%)
USD |
NASDAQ |
Oct 23, 16:00
524.09
+0.16
(+0.03%)
After-Hours: 20:00
Vertex Pharmaceuticals Price : 523.93 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 531.66 | 533.08 | 522.91 | 523.93 | 832628.0 |
| Oct 22, 2026 | 527.18 | 537.81 | 521.30 | 535.17 | 1.642M |
| Oct 21, 2026 | 512.79 | 528.57 | 510.48 | 524.52 | 1.449M |
| Oct 20, 2026 | 507.89 | 515.74 | 505.00 | 514.65 | 1.231M |
| Oct 19, 2026 | 500.00 | 505.83 | 499.50 | 501.95 | 1.299M |
| Oct 16, 2026 | 511.06 | 512.21 | 497.49 | 499.74 | 1.413M |
| Oct 15, 2026 | 514.91 | 517.68 | 507.21 | 508.75 | 2.263M |
| Oct 14, 2026 | 490.45 | 502.94 | 487.54 | 498.50 | 2.090M |
| Oct 13, 2026 | 507.55 | 508.57 | 484.08 | 485.22 | 1.188M |
| Oct 12, 2026 | 512.44 | 514.80 | 506.00 | 507.00 | 952749.0 |
| Oct 09, 2026 | 502.11 | 514.90 | 502.06 | 510.08 | 1.481M |
| Oct 08, 2026 | 503.14 | 507.87 | 498.90 | 503.25 | 1.488M |
| Oct 07, 2026 | 504.08 | 511.50 | 503.94 | 505.64 | 806841.0 |
| Oct 06, 2026 | 505.00 | 507.41 | 496.32 | 502.31 | 775071.0 |
| Oct 05, 2026 | 504.78 | 506.01 | 496.15 | 503.50 | 915135.0 |
| Oct 02, 2026 | 509.50 | 509.50 | 499.95 | 504.73 | 939659.0 |
| Oct 01, 2026 | 522.39 | 523.52 | 505.27 | 506.74 | 1.195M |
| Sep 30, 2026 | 525.26 | 529.72 | 522.74 | 522.81 | 1.146M |
| Sep 29, 2026 | 522.22 | 529.46 | 519.24 | 526.73 | 688927.0 |
| Sep 28, 2026 | 524.27 | 529.89 | 521.16 | 527.67 | 824740.0 |
| Sep 25, 2026 | 522.55 | 527.69 | 518.92 | 526.19 | 756206.0 |
| Sep 24, 2026 | 515.56 | 528.99 | 515.30 | 522.38 | 941057.0 |
| Sep 23, 2026 | 515.60 | 525.43 | 509.56 | 516.34 | 1.214M |
| Sep 22, 2026 | 521.69 | 525.97 | 508.14 | 514.99 | 1.387M |
| Sep 21, 2026 | 506.85 | 514.10 | 501.01 | 510.72 | 906682.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 156.04 |
| Sionna Therapeutics, Inc. | 3.60 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Regeneron Pharmaceuticals, Inc. | 805.02 |
| Amgen, Inc. | 439.26 |
Price Related Metrics
| PE Ratio | 30.48 |
| PS Ratio | 10.57 |
| PEG Ratio | 1.333 |
| Price to Book Value | 6.556 |
| Price to Free Cash Flow | 35.37 |
| Earnings Yield | 3.28% |
| Market Cap | 132.74B |
| PEGY Ratio | 1.333 |
| Operating PE Ratio | 26.74 |
| Normalized PE Ratio | 29.67 |